Bud Flagstad Appointed CEO of Care Angel

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Bud Flagstad is a respected leader in the healthcare technology space where he most recently held the position of senior vice president of UnitedHealth Group Research & Development.

In this role, Bud Flagstad was responsible for driving consumer and provider engagement to reduce healthcare costs, increase access to high-quality care, enhance system efficiency and efficacy, and empower consumers to maintain or improve their health and wellbeing.

“After working with Bud as an investor and advisor to Care Angel for over a year, we are excited to welcome him to the Care Angel family as CEO,” said Wolf Shlagman, Care Angel founder and former CEO.  “The timing couldn’t be better to have him lead our revenue acceleration ramp and make sure we have the right partners to help fund our exponential growth. Bud has a proven track record and experience with some of the largest players in the market using transformative healthcare products that have impacted tens of millions of lives. I look forward to scaling the organization in collaboration with him.”

As the Care Angel model evolves, Mr. Shlagman will continue to play the vital role of developing the product vision as the chief product and innovation officer. “Wolf is well known for his heavy innovation experience, and his early contributions to building the framework of what the telemedicine industry is today,” said Care Angel chairman of the board, Patrick Byrne. Mr. Shlagman is a lifelong entrepreneur with 20+ years’ experience designing products and leading teams, is the founder of Consult A Doctor, which was acquired by Teladoc Health in 2013. “In his new role, Wolf will continue to leverage his deep technology knowledge as we deliver on the vision to deploy care at scale to the most at-risk populations globally.”

Over his prominent 30+ year career, Bud Flagstad has held executive leadership roles across the health insurance, private equity, medical startup and financial services industries. During his time at UnitedHealth Group specifically, a prestigious Fortune 50 company, he also spearheaded numerous projects, strategic partnerships and acquisitions.  Mr. Flagstad earned his Bachelor of Science in computer science and business administration at Minnesota State University.

“Working with Care Angel for over a year as both an investor and an advisor made it very apparent to me the potential impact the company can have on helping to build a better healthcare system with their solutions, supporting improved outcomes, reducing costs and expanding accessibility,” said Mr. Flagstad. “I truly look forward to joining such an incredible team.”



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.